United States · FDA National Drug Code directory
nilotinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13668-711_1160ea15-94e0-4555-a86b-7eee9ef4d859
- Product NDC
- 13668-711
- Form
- CAPSULE
- Composition / generic term
- nilotinib
- Labeler
- Torrent Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251216
- Source listing expiry
- 20271231
Source-listed ingredients
- NILOTINIB HYDROCHLORIDE MONOHYDRATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (13668-711-57) / 28 CAPSULE in 1 BLISTER PACK · 13668-711-57
- 1 BLISTER PACK in 1 CARTON (13668-711-91) / 28 CAPSULE in 1 BLISTER PACK · 13668-711-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →